Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Jasper Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $70.23M | $70.23M - $70.23M | $0.00 | -$0.563 | 3 |
| Dec 2029 | $31.85M | $31.85M - $31.85M | $0.00 | -$0.943 | 3 |
| Dec 2028 | $33.88M | $33.88M - $33.88M | $0.00 | -$0.809 | 4 |
| Dec 2027 | $173.8K | $173.8K - $173.8K | $0.00 | -$1.219 | 5 |
| Dec 2026 | $1.11M | $1.11M - $1.11M | $0.00 | -$1.027 | 6 |
| Dec 2025 | $4.40M | $4.40M - $4.40M | $0.00 | -$4.38 | 5 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$4.537 | 0 |